Review
Open access
Oct 2026
Review Article: Fibrosis-4 Index in Steatotic Liver Disease-Past, Present and Future.
In the precision therapy era, FIB-4 remains a scalable front-door test but should not serve as a stand-alone selector for drug eligibility; confirmatory staging is required to identify F2-F3 disease and exclude cirrhosis.
K. Soni, V. Jahagirdar, Omar Albhaisi et al.
· Alimentary Pharmacology and... · 0 citations